| Astrocyte Precursor Cells | |
|---|---|
| Lineage | Neural Stem Cell > Astrocyte Precursor > Mature Astrocyte |
| Markers | GFAP, S100B, ALDH1L1, Nestin, Vimentin |
| Brain Regions | Cerebral Cortex, Hippocampus, White Matter, Brain Parenchyma |
| Disease Vulnerability | Alzheimer's Disease, Parkinson's Disease, ALS, Gliosis |
Astrocyte Precursor Cells (APCs) are glial progenitor cells that give rise to mature astrocytes—the most abundant cell type in the mammalian brain[1]. These cells play critical roles in brain development, homeostasis, and the response to neurodegeneration[2]. Understanding APC biology is essential for developing therapies targeting astrocyte dysfunction in neurodegenerative diseases.
Astrocyte Precursor Cells are a specialized cell type classified within the Neural Stem Cell > Astrocyte Precursor lineage[1:1]. These cells are primarily found throughout the Brain Parenchyma including the Cerebral Cortex, Hippocampus, and White Matter. They are characterized by expression of marker genes including GFAP (Glial Fibrillary Acidic Protein), S100B, ALDH1L1 (Aldehyde Dehydrogenase 1 Family Member L1), Nestin, and Vimentin. They show selective vulnerability in Alzheimer's Disease, Parkinson's Disease, ALS, and participate in Gliosis.
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:4042022 | astrocyte-restricted precursor |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:4042022 | astrocyte-restricted precursor | Exact |
Astrocyte precursor cells arise from radial glial cells during development and transition through distinct stages[3]:
Key factors driving astrocyte differentiation include:
Astrocyte Precursor Cells are identified by the expression of the following key marker genes:
These markers are used for immunohistochemical identification and single-cell RNA sequencing classification.
Astrocyte Precursor Cells play essential roles in neural circuits and brain function. Their normal functions include:
They are found throughout the brain in:
In Alzheimer's disease, astrocyte precursors undergo reactive transformation[4]:
In Parkinson's disease, astrocyte precursors contribute to disease progression[5]:
In ALS, astrocyte precursors play complex roles[6]:
Astrocyte precursors are central to gliosis—the reactive response to neural injury[7]:
Targeting astrocyte precursor cells offers therapeutic opportunities[8]:
Study of Astrocyte Precursor Cells employs various techniques:
Single-cell RNA sequencing – Transcriptomic profiling
Immunohistochemistry – GFAP, S100B, ALDH1L1 staining
Flow cytometry – Cell sorting by surface markers
Organotypic slice cultures – Ex vivo brain tissue studies
iPSC differentiation – Generating astrocytes from stem cells
Cell Types Index Astrocytes
Reactive Astrocytes
Gliosis
The study of Astrocyte Precursor Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Rowitch DH, Kriegstein AR. Developmental genetics of vertebrate glial-cell specification. Nature (2010). 2010. ↩︎ ↩︎
Freeman MR. Specification and morphogenesis of astrocytes. Science (2010). 2010. ↩︎
Miller FD, Gauthier-Fisher A. Finding the right precursors for astrocyte regeneration. Nat Med (2014). 2014. ↩︎
Liddelow SA et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature (2017). 2017. ↩︎
Zhang Y et al. Molecular landscape of astrocyte in Parkinson's disease. Nat Neurosci (2019). 2019. ↩︎
Di Giorgio FP et al. Non-cell autonomous toxicity in familial ALS. Nat Neurosci (2007). 2007. ↩︎
Pekny M, Pekna M. Reactive gliosis in the pathogenesis of CNS diseases. Nat Rev Neurosci (2016). 2016. ↩︎
Heads of the Departments. Astrocyte-based therapy for neurological disorders. Nat Rev Drug Discov (2021). 2021. ↩︎